Russia: Toxicity data required [Regulatives / Guidelines]

posted by mittyri  – Russia, 2013-09-02 16:18 (4681 d 10:43 ago) – Posting: # 11407
Views: 11,987

Hi Helmut & Karthikeyan!

Helmut knows (almost) everything ;-)

❝ ❝ i am in need of information, whether that is sufficient or we need additional toxicity or clinical trials...

❝ You need toxicity data of the formulations (test + reference!) – not only of the API – before you start a BE study.


At this moment - yes. I would pay your attention on new amends prepared by MoH and experts. They are going to be approved soon.
According to this draft it will be allowed only to post a literature review of originator's preclinical trials.
It's discussed now about data exclusivity of this data. May be it would be possible only with originator's permision (or 6 years after Originator's registration)

No one knows how would it works :confused:

❝ Anyhow, according to federal law #61 (aka “Lex Putin”)

:-D

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
280 visitors (0 registered, 280 guests [including 14 identified bots]).
Forum time: 03:01 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5